Page last updated: 2024-11-02

piracetam and Deglutition Disorders

piracetam has been researched along with Deglutition Disorders in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Deglutition Disorders: Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.

Research Excerpts

ExcerptRelevanceReference
" Levetiracetam monotherapy at a dosage of 40 mg/kg/day improved the clinical findings, and seizures were controlled at the end of the first month of treatment."1.38Acquired epileptiform opercular syndrome: F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) findings and efficacy of levetiracetam therapy. ( Akın, R; Arslan, M; Ince, S; Ünay, B; Vurucu, S; Yiş, U, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arslan, M1
Yiş, U1
Vurucu, S1
Ince, S1
Ünay, B1
Akın, R1
Mikati, MA1
El Banna, D1
Sinno, D1
Mroueh, S1

Trials

1 trial available for piracetam and Deglutition Disorders

ArticleYear
Response of infantile spasms to levetiracetam.
    Neurology, 2008, Feb-12, Volume: 70, Issue:7

    Topics: Anticonvulsants; Body Weight; Brain; Deglutition Disorders; Dose-Response Relationship, Drug; Drug A

2008

Other Studies

1 other study available for piracetam and Deglutition Disorders

ArticleYear
Acquired epileptiform opercular syndrome: F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) findings and efficacy of levetiracetam therapy.
    Epilepsy & behavior : E&B, 2012, Volume: 25, Issue:1

    Topics: Anticonvulsants; Child, Preschool; Deglutition Disorders; Dysarthria; Electroencephalography; Epilep

2012